BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31840866)

  • 1. Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.
    Trefzger OS; Barbosa NV; Scapolatempo RL; das Neves AR; Ortale MLFS; Carvalho DB; Honorato AM; Fragoso MR; Shuiguemoto CYK; Perdomo RT; Matos MFC; Chang MR; Arruda CCP; Baroni ACM
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900241. PubMed ID: 31840866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of isoxazole derivatives of tetrahydrofuran neolignans on intracellular amastigotes of Leishmania (Leishmania) amazonensis: A structure-activity relationship comparative study with triazole-neolignan-based compounds.
    das Neves AR; Trefzger OS; Barbosa NV; Honorato AM; Carvalho DB; Moslaves IS; Kadri MCT; Yoshida NC; Kato MJ; Arruda CCP; Baroni ACM
    Chem Biol Drug Des; 2019 Dec; 94(6):2004-2012. PubMed ID: 31444858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and antitrypanosomatid activities of 3,5-diaryl-isoxazole analogues based on neolignans veraguensin, grandisin and machilin G.
    Trefzger OS; das Neves AR; Barbosa NV; Carvalho DB; Pereira IC; Perdomo RT; Matos MFC; Yoshida NC; Kato MJ; de Albuquerque S; Arruda CCP; Baroni ACM
    Chem Biol Drug Des; 2019 Mar; 93(3):313-324. PubMed ID: 30354012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents.
    Tahghighi A; Marznaki FR; Kobarfard F; Dastmalchi S; Mojarrad JS; Razmi S; Ardestani SK; Emami S; Shafiee A; Foroumadi A
    Eur J Med Chem; 2011 Jun; 46(6):2602-8. PubMed ID: 21501907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing of 5-nitrofuran-3,5-disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents.
    Carvalho DB; das Neves AR; Portapilla GB; Soares O; Santos LBB; Oliveira JRS; Vianna LS; Judice WAS; Cardoso IA; Luccas PH; Nonato MC; Lopes NP; de Albuquerque S; Baroni ACM
    Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200472. PubMed ID: 36534890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-protozoal and anti-fungal evaluation of 3,5-disubstituted 1,2-dioxolanes.
    Pinet A; Cojean S; Nguyen LT; Vásquez-Ocmín P; Maciuk A; Loiseau PM; Le Pape P; Figadère B; Ferrié L
    Bioorg Med Chem Lett; 2021 Sep; 47():128196. PubMed ID: 34116159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
    da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
    Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimicrobial potential of nitrofuran-triazole congeners.
    Kamal A; Hussaini SM; Sucharitha ML; Poornachandra Y; Sultana F; Ganesh Kumar C
    Org Biomol Chem; 2015 Sep; 13(36):9388-97. PubMed ID: 26238045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity.
    Tahghighi A; Emami S; Razmi S; Rezazade Marznaki F; Kabudanian Ardestani S; Dastmalchi S; Kobarfard F; Shafiee A; Foroumadi A
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):843-52. PubMed ID: 22651800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palladium-mediated synthesis and biological evaluation of C-10b substituted Dihydropyrrolo[1,2-b]isoquinolines as antileishmanial agents.
    Barbolla I; Hernández-Suárez L; Quevedo-Tumailli V; Nocedo-Mena D; Arrasate S; Dea-Ayuela MA; González-Díaz H; Sotomayor N; Lete E
    Eur J Med Chem; 2021 Aug; 220():113458. PubMed ID: 33901901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
    Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and antileishmanial in vitro activity of new series of chalcones-like compounds: a molecular hybridization approach.
    Barbosa TP; Sousa SC; Amorim FM; Rodrigues YK; de Assis PA; Caldas JP; Oliveira MR; Vasconcellos ML
    Bioorg Med Chem; 2011 Jul; 19(14):4250-6. PubMed ID: 21684751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
    Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
    Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Antileishmanial Activity of Naphthotriazolyl-4- Oxoquinolines.
    Oliveira VG; Dos Santos Faiões V; Gonçalves GBR; Lima MFO; Boechat FCS; Cunha AC; de Andrade-Neto VV; de C da Silva F; Torres-Santos EC; de Souza MCBV
    Curr Top Med Chem; 2018; 18(17):1454-1464. PubMed ID: 30277154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
    Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
    Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of N-substituted indole derivatives as potential antimicrobial and antileishmanial agents.
    Tiwari S; Kirar S; Banerjee UC; Neerupudi KB; Singh S; Wani AA; Bharatam PV; Singh IP
    Bioorg Chem; 2020 Jun; 99():103787. PubMed ID: 32251947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexane extract from
    Souza AO; Pereira PS; Fernandes CC; Andrade G; Pires RH; Candido ACBB; Magalhães LG; Vieira TM; Crotti AEM; Martins CHG; Miranda MLD
    Nat Prod Res; 2022 Jun; 36(11):2907-2912. PubMed ID: 34034579
    [No Abstract]   [Full Text] [Related]  

  • 18. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
    Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
    Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro leishmanicidal activity of disulfide derivatives.
    Khan KM; Taha M; Naz F; Khan M; Rahim F; Samreen ; Perveen S; Choudhary MI
    Med Chem; 2011 Nov; 7(6):704-10. PubMed ID: 22313310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids.
    Baréa P; Barbosa VA; Bidóia DL; de Paula JC; Stefanello TF; da Costa WF; Nakamura CV; Sarragiotto MH
    Eur J Med Chem; 2018 Apr; 150():579-590. PubMed ID: 29549842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.